DEVELOPMENT OF ANTISENSE THERAPEUTICS - IMPLICATIONS FOR CANCER GENE-THERAPY

被引:19
作者
MILLIGAN, JF
JONES, RJ
FROEHLER, BC
MATTEUCCI, MD
机构
[1] Gilead Sciences, Foster City, California, 94404
来源
GENE THERAPY FOR NEOPLASTIC DISEASES | 1994年 / 716卷
关键词
D O I
10.1111/j.1749-6632.1994.tb21715.x
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
[No abstract available]
引用
收藏
页码:228 / 241
页数:14
相关论文
共 67 条
[1]   AN OLIGOMER COMPLEMENTARY TO C-MYB-ENCODED MESSENGER-RNA INHIBITS PROLIFERATION OF HUMAN MYELOID-LEUKEMIA CELL-LINES [J].
ANFOSSI, G ;
GEWIRTZ, AM ;
CALABRETTA, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1989, 86 (09) :3379-3383
[2]  
BENNETT CF, 1992, MOL PHARMACOL, V41, P1023
[3]   INHIBITORY EFFECTS OF ANTISENSE OLIGODEOXYNUCLEOTIDES TARGETING C-MYC MESSENGER-RNA ON SMOOTH-MUSCLE CELL-PROLIFERATION AND MIGRATION [J].
BIRO, S ;
FU, YM ;
YU, ZX ;
EPSTEIN, SE .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1993, 90 (02) :654-658
[4]  
BISCHOFBERGER N, 1992, SEMIN VIROL, V3, P57
[5]  
CALABRETTA B, 1991, CANCER RES, V51, P4505
[6]   NORMAL AND LEUKEMIC HEMATOPOIETIC-CELLS MANIFEST DIFFERENTIAL SENSITIVITY TO INHIBITORY EFFECTS OF C-MYB ANTISENSE OLIGODEOXYNUCLEOTIDES - AN INVITRO STUDY RELEVANT TO BONE-MARROW PURGING [J].
CALABRETTA, B ;
SIMS, RB ;
VALTIERI, M ;
CARACCIOLO, D ;
SZCZYLIK, C ;
VENTURELLI, D ;
RATAJCZAK, M ;
BERAN, M ;
GEWIRTZ, AM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1991, 88 (06) :2351-2355
[7]   NATURAL AND PHOSPHOROTHIOATE-MODIFIED OLIGODEOXYRIBONUCLEOTIDES EXHIBIT A NONRANDOM CELLULAR-DISTRIBUTION [J].
CERUZZI, M ;
DRAPER, K ;
SCHWARTZ, J .
NUCLEOSIDES & NUCLEOTIDES, 1990, 9 (05) :679-695
[8]  
CHIN D J, 1990, New Biologist, V2, P1091
[9]   USE OF AN ANTISENSE OLIGONUCLEOTIDE TO INHIBIT EXPRESSION OF A MUTATED HUMAN PROCOLLAGEN GENE (COL1A1) IN TRANSFECTED MOUSE 3T3 CELLS [J].
COLIGE, A ;
SOKOLOV, BP ;
NUGENT, P ;
BASERGA, R ;
PROCKOP, DJ .
BIOCHEMISTRY, 1993, 32 (01) :7-11
[10]  
DAAKA Y, 1990, ONCOGENE RES, V5, P267